Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Novartis Elidel in Phase IIRespiratory system
Shire Elaprase Approved in USA, EU and JapanAlimentary tract & metabolism
IDM Pharma Eladem accomplished Phase IIAntineoplastic & immunomodulating agents
Clavis Pharma ELACYT in Phase IIAntineoplastic & immunomodulating agents
Clavis Pharma ELACYT in Phase IIAntineoplastic & immunomodulating agents
Wyeth Effexor XR Panic Approved in USA, submitted for approval in EUNervous system
MacroChem EcoNail in Phase IIDermatologicals
Lundbeck Ebixa Approved in EU, USA and CanadaNervous system
Dainippon Sumimoto Pharma EBASTEL Submitted for approval in USARespiratory system
Bristol-Myers Squibb E2F Decoy discontinuedCardiovascular system
Sanofi-aventis Dynepo Submitted for approval in USABlood & blood forming organs
Pfizer Dynastat discontinuedNervous system
Pfizer Dynastat in Phase IIIMusculoskeletal system
Johnson & Johnson DURAGESIC 12 Submitted for approval in USANervous system
Johnson & Johnson DOXIL and Velcade Approved in USAAntineoplastic & immunomodulating agents
Johnson & Johnson DOXIL accomplished Phase IIIAntineoplastic & immunomodulating agents
Johnson & Johnson DOXIL Approved in USAAntineoplastic & immunomodulating agents
Johnson & Johnson DORIBAX Approved in USAAnti-infectives for systemic use
Novartis Diovan Value in Phase IIICardiovascular system
Novartis Diovan Valiant Submitted for approval in EU and USACardiovascular system
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.